2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE

Product Information

Molecular Formula:
C14H21BO4
Molecular Weight:
264.13
Description
2-(3,5-Dimethoxy)-phenyl-4,4,5,5-tetramethyl-(1,3,2)-dioxaborolane is a biomedicine product used in the drug development of certain diseases. It plays a crucial role as a pharmaceutical intermediate, assisting in the synthesis of various drugs targeting specific conditions. The compound's unique structure and properties make it valuable in drug discovery and development processes within the biomedical industry.
Synonyms
2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE; 3,5-DIMETHOXYPHENYLBORONIC ACID, PINACOL ESTER
IUPAC Name
2-(3,5-dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Canonical SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC(=CC(=C2)OC)OC
InChI
InChI=1S/C14H21BO4/c1-13(2)14(3,4)19-15(18-13)10-7-11(16-5)9-12(8-10)17-6/h7-9H,1-6H3
InChI Key
CZYHRTIJLUONKY-UHFFFAOYSA-N
Melting Point
90-94 °C (lit.)
Purity
96%
Appearance
White powder to off-white powder and/or chunks

Computed Properties

Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
3
Exact Mass
264.1532893 g/mol
Monoisotopic Mass
264.1532893 g/mol
Topological Polar Surface Area
36.9Ų
Heavy Atom Count
19
Formal Charge
0
Complexity
291
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
WO-2021262684-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION 2020-06-22
US-2021171535-A1 Tricyclic heterocycles as fgfr inhibitors 2019-12-04
WO-2021113479-A1 Tricyclic heterocycles as fgfr inhibitors 2019-12-04
EA-037563-B1 NEW (HETERO) ARYL-SUBSTITUTED PIPERIDINYL DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 2016-12-28
EP-3486244-A1 New compound having fgfr inhibitory activity and preparation and application thereof 2016-06-16
JP-2019521992-A Novel compounds having FGFR inhibitory activity and their production and use 2016-06-16
US-2019367520-A1 New compound having fgfr inhibitory activity and preparation and application thereof 2016-06-16
WO-2017215485-A1 New compound having fgfr inhibitory activity and preparation and application thereof 2016-06-16
CA-3027008-A1 (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them 2016-06-10
CA-3027014-A1 Piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them 2016-06-10
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Top
Inquiry Basket